Treatment of breast cancer in postmenopausal women

Faslodex 250mg Injection contains the active constituent fulvestrant. It is used in the treatment of estrogen receptor-positive metastatic breast cancer in postmenopausal women. It is also used in combination with Palbociclib in the treatment of hormone receptor-positive, and human epidermal growth factor 2-negative breast cancer (metastatic). It is not recommended in patients with chronic liver problems.

#breastcancer #Breastcancertreatment #cancertreatment #breastcancerawareness

Know more about Faslodex 250mg injection